FDA issues final guidance on driving-ability clinical trial data submissions
Start here
The FDA's Center for Drug Evaluation and Research has issued a final Level 2 guidance setting out the technical specifications for submitting clinical trial data used to evaluate a drug's effect on the ability to operate a motor vehicle. Such data can support marketing applications for drugs and biological products, and sponsors must now follow the prescribed submission format. The guidance is final, so this step of the process is complete.
Written by a model from the reports · updated 4 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- U.S. FDAPickSubmitting Clinical Trial Data to Evaluate the Ability to Operate a Motor Vehicle
FDA's Center for Drug Evaluation and Research has issued a final Level 2 guidance specifying the technical specifications for submitting clinical trial data used to evaluate the ability to operate a motor vehicle in support of marketing applications for drugs or biological products.
Coverage and heat for this story
Reports so far 1·Heat now 9·Peak heat 10 (Oct 21 01:00)·Reports, 24h +1
Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.